1/67
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
what is darbepoetin alfa classified as
epoetin alfa
Epoetin Alfa (Darbepoetin Alfa) use
•Anemia associated with CRF, chemotherapy, HIV pts taking zidovudine, pre-surgery
•Essentially erythropoietin
•Stimulates process of RBC
Epoetin Alfa (Darbepoetin Alfa) AEs
• HTN MUST be controlled (if pre-existing -> do not start until controlled)
• Thrombotic Event (due to increase of Hgb and body has to get used to new thickness of blood) happens when : Hgb ≥11 g/dL or Hgb increase > 1 g/dL in 2 weeks
•DVT (pre-op)
•HA & Body Aches
Epoetin Alfa (Darbepoetin Alfa) nursing
Contraindicated: uncontrolled HTN & some cancers
SQ or IV bolus
Do not shake vial (will denature med)
Do not mix with any other meds
what should we monitor with Epoetin Alfa (Darbepoetin Alfa)
•BP
•Hgb & Hct (we don’t want hgb to go above 10 or 11 due to high risk of thrombotic events)
•Iron Levels:
•Transferrin Saturation ≥ 20%
•Ferritin Concentration ≥ 100 ng/mL
•Need adequate iron stores to produce RBC
Filgrastim (Pegfilgrastim) uses
•Stimulate bone marrow to increase production of neutrophils
•Lower infection risk in neutropenia
Filgrastim (Pegfilgrastim) AEs
•Elevated plasma uric acid, lactate dehydrogenase, alkaline phosphatase
•Bone Pain -> give them medicine for pain (acetaminophen)
•Leukocytosis
•Splenomegaly -> risk for splenic rupture
•LUQ / L Shoulder tip pain
when do we give Filgrastim (Pegfilgrastim)
WBC > 100,000 / mm3 or Absolute Neutrophils > 10,000 / mm3
Filgrastim (Pegfilgrastim) nursing considerations
•Contraindicated – Sensitive to E. coli protein
•Caution – Bone marrow cancer, sickle-cell or respiratory disease, breastfeeding, children
•SQ or IV (do not shake vial)
•Monitor CBC
Eltrombopag, Avatrombopag, Lusutrombopag, Eltrombopag, Romiplostim are classified as
thromobopoietin receptor agonists
Thrombopoietin Receptor Agonists (Eltrombopag, Avatrombopag, Lusutrombopag, Eltrombopag, Romiplostime) use
•Platelet enhancers
•Aim for Platelets >50,000
•Once it hits that platelet count we stop the medicine
Thrombopoietin Receptor Agonists (Eltrombopag, Avatrombopag, Lusutrombopag, Eltrombopag, Romiplostime) AES
•Fever, cough, HA, nausea, edema
•Thromboembolism risk
•Hepatotoxicity
oral preparations of iron?
Ferrous sulfate, Ferrous gluconate, Ferrous fumarate
parenteral preparations of iron (much less commonly given)
Iron dextran, Ferumoxytol, Iron sucrose, Sodium-ferric gluconate complex (SFGC)
AEs of iron preparations
•GI distress Nausea, Constipation, Heartburn
•Empty stomach
•Black / dark green stool
•Teeth staining use water, juice, or straw
• parenteral administration: skin staining, anaphylaxis, hypotensions
•Fatal toxicity in children (look like candy so BE CAREFUL)
•Deferoxamine (antidote) & Gastric lavage
• Will have n/v, shock, diarrhea
nursing considerations of iron preparations
•Interactions – Antacids, tetracycline, caffeine, dairy, food all block iron absorption
•Take on empty stomach (1 hr before meals)
•Dark stools (black / dark green) & constipation
•Increase water and fiber
•Dillute liquid with water/juice, use a straw, rinse mouth after
•Vitamin C greatly enhances absorption take w small glass of OJ on empty stomach
•Eat high iron foods
vitamin b12 (cyanocobalamin) AEs
• Hypokalemia
• GI distress N/V/D, dyspepsia, abdominal discomfort
• Paresthesias
vitamin b12 (cyanocobalamin) nursing considerations
•Folic acid masks S/S Vitamin B12 deficiency
•Monitor through labs or don’t give at same time
•Monitor CBC, Vitamin B12, folate
•Intranasal 1 hr before hot foods
folic acid AEs
•Masks S/S Vitamin B12 deficiency
• Diarrhea, Anorexia, Fatigue, SOB, Dizziness, Pallor, HA,Swollen tongue, Mouth Sores, Memory / Growth issues
what are the thromboembolic drugs?
anticoagulants, antiplatelets, thrombolytics
unfractioned heparin is used for what
• Rapid (Stroke, PE, DVT), Prevention (post-op DVT)
• Open-heart surgery, renal dialysis to prevent clot formation since blood Is going into machine
• Preferred during pregnancy
nursing considerations for heparin (unfractioned)
•Monitor – aPTT (increases) activated partial thromboplastic time (normal usually 40 sec)
•Number should be between 60-80 sec tbh)
•Is checked every 4-6 hours
•Platelets, Hct
interactions for heparin unfractioned
antiplatelet meds, garlic, ginger, glucosamine, ginkgo, saw palmetto à increased bleeding
•Bruising, bleeding gums, abdominal pain, nosebleeds, hematemesis, melena
Use electric razor, soft toothbrush
heparin (unfractioned) AEs
•Toxicity
•Bleeding:↑HR, ↓BP, bruising, petechiae, hematomas, melena
•Heparin-induced thrombocytopenia (HIT) decreased platelet count due to heparin
•Spinal/epidural hematoma
•Hypersensitivity
what to give for heparin (unfractioned) toxicity
•Protamine Sulfate (antidote)
•slow IV infusion → ≤20mg/min or 50mg/10min AND <100 mg / 2 hrs
•1 mg protamine for 100 units of heparin
enoxaparin & dalteparin are classified as what
low-Molecular-Weight (LMW) Heparins
Low-Molecular-Weight (LMW) Heparins (enoxaparin, dalteparin) uses
•DVT & PE (treat or prevent i.e. post-op)
•Prevent ischemic complications in angina, non-Q-wave MI, STEMI
•During pregnancy
Low-Molecular-Weight (LMW) Heparins (enoxaparin, dalteparin) AEs
•Toxicity → Protamine Sulfate antidote
•Bleeding
•Heparin-induced thrombocytopenia (HIT)
•Spinal/epidural hematoma
fondaparinux use
•Not really a heparin but acts like it
•Inactivate Factor Xa
•Prevent post-op DVT & PE
•Treat DVT or PE (with warfarin)
nursing considerations for the anticoagulants (Low-Molecular-Weight (LMW) Heparins (enoxaparin, dalteparin) & fondaparinux)
•NO Monitoring!
•SQ injections – rotate abdomen
•Interactions
•Antiplatelet meds, garlic, ginger, glucosamine, ginkgo, saw palmetto à increased bleeding
•S/S bleeding: Bruising, bleeding gums, abdominal pain, nosebleeds, hematemesis, hematochezia
•Use electric razor, soft toothbrush
fondaparinux AEs
Bleeding
Spinal/epidural hematoma
NO HIT WOOO
Decreased platelets
•D/C platelets <100,000/mm3
what is HIT
complication of exposure to heparin & usually occurs after 4+ days of heparin therapy
what you will see in HIT
•Thrombocytopenia
•Platelets < 150,000
•Platelet count reduction >50% from baseline
what should a patient who has experienced HIT before be aware of
They should NEVER EVER receive heparin or a LMWH for LIFE (aka heparin allergy)
don’t stop anticoagulation suddenly because of risk of thrombi
what do we do with HIT
•Stop heparin!
•We would then anticoagulate with a non-heparin anticoagulant (unless they are just totally bleeding)
•Argatroban
•Bivalirudin
•Fondaparinux
•We start another anticoagulant because they are at increased risk of thrombosis
what should we check for with patients who are anticoagulated with Heparin, LMWHs, or Fondaparinux and are receiving neuraxial anesthesia or undergoing spinal puncture
spinal/epidural hematomas since they can result in long-term or permanent paralysis
what is warfarin (vit k inhibitor) use
to prevent DVT, PE, A Fib, Prosthetic Heart Valves, Post-MI or TIA
warfarin (vit K inhbitor) nursing considerations
•Monitor – PT/INR
•This med does not work immediately
•Contraindicated in Pregnancy
•Use heparin
•Interaction – decreased anticoagulation
•phenobarbital, carbamazepine, phenytoin, oral contraceptives, Vitamin K, CoQ-10
•Watch Vitamin K foods
•dark green leafy veggies, mayo, canola oil
•Make sure they are not having big vitamin K shift bc it affects the warfarin
•Oral – once daily – same time
•Long ½ life
•Avoid EtOH & OTC meds
•Medical alert bracelet
warfarin (vit K inhbitor) AEs
bleeding
hepatitis
toxicity
what to do for warfarin toxicity
give vitamin K1
PO 2.5 mg
IV 0.5-1 mg diluted & infused slowly
(Dabigatran, bivalirudin, desirudin, argatroban) are classified as
direct thrombin inhibitors
AEs of direct thrombin inhibitors (dabigatran, bivalirudin, desirudin, argatroban)
•Bleeding
•GI N/V, reflux, ulcers, GI discomfort
•Bivalirudin: Back pain, nausea, hypotension, HA
•Desirudin: Injection-site mass, anemia, nausea, deep thrombophlebitis
•Interactions: Thrombolytics, anticoagulants, herbals, Dabigatran – several interactions
rivaroxaban, apixaban, edoxaban are classified as what
direct factor Xa inhibitors
direct factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) use
•A Fib (Stroke prevention), prevent/treat DVT or PE (general + THA or TKA)
•They block factor Xa
direct factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) AEs
•Bleeding
•Elevated liver enzymes & bilirubin
•Many drug interactions
•All po
•Monitor Hgb, Hct, Liver & Kidney function
what are the antiplatelet drugs
•Cyclooxygenase (COX) Inhibitor
•P2Y12 ADP Inhibitors
•Glycoprotein IIb/IIIa Inhibitors
•Arterial Vasodilators
antiplatelet drugs uses
•MI prevention
•Post-MI prevention
•Stroke / TIA prevention
•Acute coronary syndromes
•GP Inhibitors
•ADP Inhibitors
•Intermittent Claudication
•Arterial Vasodilators
Cox inhibitor- Aspirin (ASA) AEs
•GI – N/V, dyspepsia
•Hemorrhagic Stroke
•Prolonged bleeding time, gastric bleed, thrombocytopenia
•Tinnitus / Hearing Loss
Cox inhibitor- Aspirin (ASA) nursing considerations
•Pregnancy NOT SAFE DURING 3rd trimester (don’t use)
•81 mg (Prevention give baby aspirin to preveny MI, stroke) if they a skip a day they’ll be fine bc anticoagulation lasts a week)
•325 mg standard dose of aspirin (Initial acute MI)
clopidogrel, ticagrelor, prasugrel, cangrelor are classified as what
P2Y 12 ADP inhibitors
P2Y 12 ADP inhibitors (clopidogrel, ticagrelor, prasugrel, cangrelor) use
Primarily used for patients w stent place or cardiac cath
P2Y 12 ADP inhibitors (clopidogrel, ticagrelor, prasugrel, cangrelor) AEs
Bleeding
•GI diarrhea, dyspepsia, pain
P2Y 12 ADP inhibitors (clopidogrel, ticagrelor, prasugrel, cangrelor) nursing considerations
•Lactation – NO
•CYP450 interactions
•D/C 5 – 7 days before elective surgery
Eptifibatide, Tirofiban are classified as what
Glycoprotein (GP) IIb/IIIa inhibitors
Glycoprotein (GP) IIb/IIIa inhibitors - (Eptifibatide, Tirofiban) uses
•For Acute Coronary Syndromes & Percutaneous Coronary Interventions (PCI)
•Basically super aspirin
Glycoprotein (GP) IIb/IIIa inhibitors - (Eptifibatide, Tirofiban) AEs
•Prolonged bleeding time, GI bleed, thrombocytopenia
•Bleeding from cardiac cath site
•Hypotension & Bradycardia
dipyridamole & cilostazol are classified as what
arterial vasodilators
arterial vasodilators use
•Dipyridamole : Thromboembolism prevention – heart valve – with warfarin or ASA
•Cilostazol : Intermittent claudication
arterial vasodilators (dipyridamole, cilostazole) nursing considerations
•Lactation – NO
•Intermittent Claudication
•Pain, cramping in lower legs
•Worse with walking or exercise
•Primary symptom of peripheral vascular disease (PVD)
what is percutaneous coronary intervention (PCI)
Anticoagulant
Antiplatelet
Aspirin AND
P2y12ADP receptor antagonist OR glycoprotein IIb/IIIa receptor antagonist
alteplase (tPA), tenecteplase, reteplase are classified as what
thrombolytics
Alteplase (tPA) use
main thrombolytic we want to use
We want to use as soon as possible within 2-4 hrs
If we give it within 2 hrs the mortality rate is 5%
You give IV bolus and then hang bottle up and infuse over 90 min
AE of thrombolytics (alteplase, tenecteplase, reteplase)
•Bleeding:
•pressure dressing if blood is coming out from IV site
•whole blood, PRBC, FFP
•Aminocaproic acid reverses this
•ASAP after event
treatment for pulmonary embolism/DVT
•Anticoagulation
•Direct oral anticoagulants (DOACs) – dabigatran, rivaroxaban, apixaban, edoxaban
•Warfarin +
•LMWH – Enoxaparin or Dalteparin
•Heparin (Unfractioned)
•Fondaparinux
•Argatroban
•IVC filter: if anticoagulation is contraindicated
cerebular vascular accident (CVA) causes
•Ischemic – vascular occlusion or stenosis
•Hemorrhagic – ICH or SAH
•Ischemic > Hemorrhagic
immediate intervention for cerebral vascular accident (CVA)
CT head (or MRI)
ischemic CVA treatment
•Acute – IV alteplase within 3 – 4.5 hours of onset of symptoms
•Aspirin (ASA) or Clopidogrel (Plavix) or Ticagrelor + ASA
•Atorvastatin
•Supportive Care
•HTN, blood glucose, fever
hemorrhagic CVA treatment
•Discontinue all anticoagulant/antiplatelet drugs
•Reversal of anticoagulant drugs:
•Vitamin K – warfarin
•Protamine – heparin, LMWH
•Idarucizumab – dabigatran
•Andexanet alfa – DOACs